Andrea Feldstain1,2,3, Sophie Lebel4, Martin R Chasen5,6,7. 1. Department of Psychosocial and Rehabilitation Oncology, Tom Baker Cancer Centre, 2202 2nd st. SW, Calgary, AB, T2S 3C1, Canada. andrea.feldstain@albertahealthservices.ca. 2. School of Psychology, Faculty of Social Sciences, University of Ottawa, 136 Jean-Jacques Lussier, Vanier Hall Ottawa, Ottawa, ON, K1N 6N5, Canada. andrea.feldstain@albertahealthservices.ca. 3. Bruyère Research Institute, Bruyère Continuing Care, Ottawa, ON, Canada. andrea.feldstain@albertahealthservices.ca. 4. School of Psychology, Faculty of Social Sciences, University of Ottawa, 136 Jean-Jacques Lussier, Vanier Hall Ottawa, Ottawa, ON, K1N 6N5, Canada. 5. Bruyère Research Institute, Bruyère Continuing Care, Ottawa, ON, Canada. 6. Medical Oncologist/Medical Director of Palliative Care, William Osler Health System, 2100 Bovaird Dr E, Brampton, ON, L6R 3J7, Canada. 7. Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Abstract
PURPOSE: Patients with advanced cancer have increased life expectancy but suffer from ongoing burden. Depressive symptomatology is their most common mental health concern. The Ottawa Palliative Rehabilitation Program (PRP) offers rehabilitation for this population. It offers 8 weeks of individualized interdisciplinary rehabilitation, post cancer treatment. Interventions include medical (physician and nurse), physiotherapy, occupational therapy, dietary, and social work using a general self-efficacy framework. Pilot data suggest benefits in a range of domains, including ratings of feeling "depressed." We examined whether reduced symptomatology was maintained 3 months after PRP completion. METHODS: Participants with advanced heterogeneous cancers who completed the PRP were mailed the Hospital Anxiety and Depression Scale (among others) 3-month post-PRP (n = 44). Demographic and medical information were obtained from patient files. RESULTS: There was a significant linear trend (mean T1: 6.79 ± 2.29; T2: 5.23 ± 3.06; T3: 4.59 ± 3.34; p = 0.007) with statistically and clinically significant decreases in reported depressive symptomatology between T1 and T2 (p = 0.042) and T1 and T3 (p = 0.007). There was a significant decreases in number of cases reporting symptomatology scores in the clinical range from T1 to T3 (p = 0.038). CONCLUSION: Patients who undergo a palliative rehabilitation program may experience relief of mild depressive symptomatology, maintainable 3-month post-PRP. The sample was exhibiting mild symptomatology and these results may not be generalizable to those with higher scores; a lack of specialized psychosocial clinician may have affected the acquired sample. Experimental designs are needed to more thoroughly compare these findings to independent rehabilitation interventions.
PURPOSE:Patients with advanced cancer have increased life expectancy but suffer from ongoing burden. Depressive symptomatology is their most common mental health concern. The Ottawa Palliative Rehabilitation Program (PRP) offers rehabilitation for this population. It offers 8 weeks of individualized interdisciplinary rehabilitation, post cancer treatment. Interventions include medical (physician and nurse), physiotherapy, occupational therapy, dietary, and social work using a general self-efficacy framework. Pilot data suggest benefits in a range of domains, including ratings of feeling "depressed." We examined whether reduced symptomatology was maintained 3 months after PRP completion. METHODS:Participants with advanced heterogeneous cancers who completed the PRP were mailed the Hospital Anxiety and Depression Scale (among others) 3-month post-PRP (n = 44). Demographic and medical information were obtained from patient files. RESULTS: There was a significant linear trend (mean T1: 6.79 ± 2.29; T2: 5.23 ± 3.06; T3: 4.59 ± 3.34; p = 0.007) with statistically and clinically significant decreases in reported depressive symptomatology between T1 and T2 (p = 0.042) and T1 and T3 (p = 0.007). There was a significant decreases in number of cases reporting symptomatology scores in the clinical range from T1 to T3 (p = 0.038). CONCLUSION:Patients who undergo a palliative rehabilitation program may experience relief of mild depressive symptomatology, maintainable 3-month post-PRP. The sample was exhibiting mild symptomatology and these results may not be generalizable to those with higher scores; a lack of specialized psychosocial clinician may have affected the acquired sample. Experimental designs are needed to more thoroughly compare these findings to independent rehabilitation interventions.
Authors: Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux Journal: N Engl J Med Date: 2011-05-12 Impact factor: 91.245
Authors: Tim Luckett; Phyllis N Butow; Madeleine T King; Mayumi Oguchi; Gaynor Heading; Nadine A Hackl; Nicole Rankin; Melanie A Price Journal: Support Care Cancer Date: 2010-07-02 Impact factor: 3.603
Authors: Jean M Fils; Elizabeth C Penick; Elizabeth J Nickel; Ekkehard Othmer; Cherilyn Desouza; William F Gabrielli; Edward E Hunter Journal: Prim Care Companion J Clin Psychiatry Date: 2010
Authors: Gillian E Mead; Wendy Morley; Paul Campbell; Carolyn A Greig; Marion McMurdo; Debbie A Lawlor Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: Catherine M Tangen; James R Faulkner; E David Crawford; Ian M Thompson; Daisaku Hirano; Mario Eisenberger; Maha Hussain Journal: Clin Prostate Cancer Date: 2003-06
Authors: Charlie C Hall; Jane Cook; Matthew Maddocks; Richard J E Skipworth; Marie Fallon; Barry J Laird Journal: Support Care Cancer Date: 2019-04-03 Impact factor: 3.603
Authors: Marie Fallon; Barry J Laird; Charlie C Hall; Lucy Norris; Liz Dixon; Jane Cook; Matthew Maddocks; Catriona Graham; Sharon Tuck; Erna Haraldsdottir; Duncan Brown; Anna Lloyd; Anne Finucane; Peter Hall; Katharina Diernberger; Richard J E Skipworth Journal: Pilot Feasibility Stud Date: 2018-12-27